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Liposomes are self-assembled nanoparticles in which lipid bilayers
encapsulate a volume of aqueous solution. They have been considered
for a long time as one of the most promising delivery systems; their
similarity to cell membranes makes them useful as a biomembrane
model as well [1–3]. Because of their biocompatibility, biodegrad-
ability, low toxicity and low immunogenicity, the most valuable
application of liposomes is in drug delivery, especially as intravenous
drug carrier. Their pronounced instability in biological environments,
such as in blood circulation, has been the reason for developing
speciﬁc steric stabilization by grafting inert hydrophilic polymers such
as PEG to their surface. Indeed, incorporation of PEG-lipid conjugates
into the lipid bilayers (stealth liposomes) can signiﬁcantly increase
the liposome stability and prolong, by several orders of magnitude,
their blood circulation times after systemic administration [4]. Thus,
the grafted polymer acts as a steric barrier and reduces the level of
plasma protein binding and uptake by phagocytic cells.
Problems associated with the liposome preparation include colloidal
instability, difﬁculties with scale-up, sterilization, and irreproducibility
between batches. The methods for liposome preparation typically
include dissolving lipids in organic solvent, with subsequent solventremoval and hydration, which result in the formation of multilamellar
vesicles (MLV). For some applications, small unilamellar vesicles (SUV)
are preferred, which can be produced from MLV by various techniques
such as sonication, extrusion through membranes, French press
extrusion, etc. [3,5]. Processes like solvent removal, extrusion and
homogenization may expose liposomal components to extreme,
possibly damaging, conditions such as elevated pressures and tempera-
tures, and high shear. The solution of someof these problems is provided
by the recently introduced diacylglycerol-PEG lipid conjugates [6–9].
They spontaneously form liposomes in aqueous media due to their
appropriate packing parameters, and exhibit steric stability due to the
grafted polymer. Here we report results on the physico-chemical
properties of two such compounds comprising dioleate or dipalmitate
hydrophobic cores, and PEG12 or PEG23 hydrophilic moieties, respec-
tively: glyceryl dioleate-PEG12 (GDO-PEG12) and glyceryl dipalmitate-
PEG23 (GDP-PEG23) (Fig. 1). Their encapsulation capacity for lipophilic
dietary supplements is also examined (although, in the context of drug
carriers, the term “encapsulation” ismore frequently used to indicate the
presence of cargo inside the aqueous inner compartment of liposomes,
generally it should not be limited to that; here we used it to indicate the
inclusion of hydrophobic drugs in the core of the lipid bilayer).
2. Materials and methods
2.1. Materials
Glyceryl dioleate-PEG12 (GDO-PEG12) (BioZone Laboratories, Inc.
Pittsburg, CA 94565), glyceryl dipalmitate-PEG23 (GDP-PEG23)
Fig. 1. Structures of the PEG lipids used in the study.
Fig. 2. Heating and cooling thermograms of a GDP-PEG23 aqueous dispersion.
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Concentrate (LipConc) (GDP-PEG23/soybean lecithin 1:1 wt/wt)
(Biopharma Scientiﬁc, Inc. San Diego, CA 92121), 1,2-Dipalmitoyl-sn-
3-phosphocholine (DPPC), 1,2-Dioleoyl-sn-3-phosphoethanolamine
(DOPE) from Avanti Polar Lipids (Birmingham, AL); Coenzyme Q10
(CoQ10), Vitamin E, Vitamin D (Fisher Scientiﬁc), Fish Oil, Immune Oil
(Pharmax LLC).
2.2. Sample preparation
Dispersions of lipids and lipid / dietary supplement mixtures were
prepared in two different ways: (i) by dissolving the compounds in
organic solvent (typically chloroform), followed by the solvent
removal under argon and overnight evacuation; aqueous phase was
then added followed by vortex-mixing. Typically, several cycles of
freezing–thawing have been applied to the lipid aqueous dispersions,
in order to attain maximum hydration and sample homogeneity. (ii)
Dry preparation: lipid dispersions were prepared by direct addition of
aqueous phase to the lipid; for mixed samples, the compounds were
initially mixed in dry state, then aqueous phase was added, followed
by vortex-mixing (in mixtures, wt/wt is used to indicate lipid/lipid or
lipid/oil weight ratio). For preparing dispersions of GDP-PEG23,
which is solid at room temperature, both lipid and aqueous phase
were heated to 60 °C prior to mixing; at that temperature GDP-PEG23
was a transparent viscous ﬂuid. For the lipid exchange experiments,
equal volumes of dispersions with the same weight fraction of lipid
have been mixed. The lipid concentration of the dispersions was
typically 2 wt.% for DSC samples, 20 wt.% for the X-ray experiments
and 0.01–0.1 wt.% for the light scattering samples.
2.3. Differential scanning calorimetry (DSC)
Measurements were performed using a VP-DSC Microcalorimeter
(MicroCal Inc., Northampton, MA) at 30 °C/h. Thermograms were
analyzed using OriginLab (Northampton, MA) software.
2.4. Synchrotron small-angle X-ray diffraction (SAXD)
Measurements were performed at Argonne National Laboratory,
Advanced Photon Source, DND-CAT (beamline 5-IDD) and BioCAT
(beamline 18-ID), using 12 keV (λ=1.033 Å) X-rays, as previously
described [10]. The lipid concentration of the dispersions was 20 wt.%.
Samples were ﬁlled into glass capillaries and ﬂame-sealed. A Linkam
thermal stage (Linkam Sci Instruments, Surrey, England) provided
temperature control. Linear heating and cooling scans were per-
formed at rates of 1–5 °C/min. Exposure times were typically ∼0.5 s.
Data were collected using a MAR-CCD detector. Sample-to-detector
distance was 1.8–2 m. Diffraction intensity vs. Q plots were obtainedby radial integration of the 2D patterns using the interactive data-
evaluating program FIT2D [11]. Some samples with longer exposure
time were checked by thin layer chromatography after the experi-
ments. Products of lipid degradation were not detected in these
samples and radiation damage of the lipids was not evident from their
X-ray patterns.
2.5. Dynamic light scattering
Measurementswere performedwith a Brookhaven Instrumentwith
BI-200SM goniometer and BI-9000 digital correlator (Brookhaven, NY).
Lipid dispersions in PBS were prepared at 100 µg/ml. Measurements
were carried out at 37 °C. Borosilicate glass, 250 µl, 3×30mm, ﬂat
bottom tubes were used. Delay times of 10 µs–1 s were examined. The
correlation data were ﬁtted with quadratic cumulants, using the
algorithm provided with the instrument.
2.6. Transmission electron microscopy
2.6.1. Fixation and embedding
Samples were washed with PBS and ﬁxed with 2% Glutaraldehyde
(GA) in 0.1 M Cacodylate buffer, pH 7.3 at 4 °C for 30 min. The
material was washed in the Cacodylate buffer and post-ﬁxed in 2%
OsO4 for 30 min at 4 °C and then thoroughly washed again. Cells were
dehydrated in ethanol solutions at increasing concentrations of 60%,
70%, 80%, 95% and 100% followed by inﬁltration with Epoxy
embedding medium, transferred into fresh Epoxy resin and polymer-
ized at 64 °C for 48 h. Sections of 65 nm thickness were cut on a Leica
ultramicrotome, stained with Uranyl acetate and post-stained with
Reinold's. Thin sections were examined on Philips CM12 transmission
electron microscope at 100 kV and micrographs were taken on ﬁlm.
3. Results and discussion
3.1. Phase behavior of diacylglycerol-PEG lipid conjugates
3.1.1. GDP-PEG23
Aqueous dispersion of GDP-PEG23 was prepared by direct mixing
of lipid and water at 60 °C, followed by overnight equilibration at
room temperature. Dispersion exhibits double endotherm (two
sequential endotherms) upon initial heating (Fig. 2), with speciﬁc
heat maxima at 13.5 °C and 28 °C. The peak at 13.5 °C increases its
enthalpy upon low-temperature incubation, while the peak at 28 °C
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thermograms. The observed hysteresis is suggestive for phase
metastability. In PBS (50 mM phosphate buffer, 100 mM NaCl, pH
7.2), the temperatures of the endotherms are close to those inwater. A
similar complex transition pattern has been reported for other
saturated diacylglycerol-PEG conjugates [7].
According to the small-angle X-ray diffraction data, GDP-PEG23
forms a lamellar phase at room temperature, with lamellar repeat
period d=9.6 nm (Fig. 3A). This is considerably larger than the
lamellar spacings of other saturated dipalmitoyl glycerolipids (e.g.,
d∼6.4 nm for DPPC, d∼6.0 nm for DPPE [12]). The difference is
apparently due to the voluminous PEG-chains conjugated to the
glycerol backbone (Fig. 1). Noteworthy is the peculiar diffraction
intensity distribution, with a strongly dominating lamellar second
order, suggestive of an unusual electron density distribution, as well
as the broad hump underlying the lamellar reﬂections. Upon heating,
the lamellar reﬂections disappear, and only the broad hump remains
at temperatures above 35 °C. Such diffraction humps are indicative of
small aggregates, lacking repeat order, such as uni- or oligolamellar
liposomes (or micelles), with uncorrelated bilayers. Since GDP-PEG23
comprises saturated palmitoyl chains, the recorded transition pre-
sumably reﬂects the gel-liquid crystalline (melting) of the lipid
hydrocarbon chains. Considering the large difference in the scan rate
of the calorimetric and X-ray diffraction experiments, the tempera-
ture discrepancy between the major endothermic event at ∼28 °C,
and the X-ray data, recording the disappearance of the ordered
lamellar phase above 30 °C, could be anticipated.
Upon cooling, the lamellar phase does not restore. A highly
ordered diffraction pattern, with spacings in the ratio of 1:1/√3:1/2,
characteristic of a hexagonal phase arrangement, appears at ∼40 °CFig. 3. SAXD patterns of a GDP-PEG23 aqueous dispersion, recorded upon initial
heating (A), and subsequent cooling–heating cycle (B).(Fig. 3B). It persists on cooling to ∼10 °C, and converts to a strongly
disordered, uncorrelated lamellar phase. The lamellar-hexagonal
transition is reversible: the hexagonal phase is observed in the
temperature interval ∼20–50 °C during the subsequent heating scan.
The observed hexagonal phase is characterized by a relatively large
unit cell dimension, a=2d10/√3=8.3 nm, by almost 2 nm larger
than that of dipalmitoleoyl phosphatidylethanolamine, comprising
the same 16C hydrocarbon chainlength [13]. From the diffraction data
only, it is impossible to distinguish between normal (oil-in-water,
type I) and inverted (water-in-oil, type II) hexagonal phase.
Considering the voluminous PEG-chains conjugated to the lipid
glycerol backbone, however, it seems hardly possible to accommodate
the inverted hexagonal phase. The observed phase sequence is also
suggestive of a normal type hexagonal phase. Upon equilibration at
room temperature for 12 h, cubic phase developed in coexistence
with the hexagonal phase (Fig. 3B, inset). The observed reﬂections are
insufﬁcient for its unambiguous identiﬁcation, but from the initial
reﬂections ratio as 1/√6:1/√8:1/√14 it might be supposed to be the
Ia3d (gyroid) phase [14].
The phase behavior of the PEG-diacylglycerol conjugates is
substantially different from that of the PEG-phospholipid conjugates,
which do not form lamellae, but have been reported to arrange into
micelles in their liquid crystalline state [15]. A likely reason for the
difference is the lack of an electric charge in the PEG-diacylglycerol
conjugate headgroups. Indeed, the PEG-derivatization of phospholi-
pids leaves an uncompensated negative charge at the phosphate
group, thus signiﬁcantly enhancing the effective size of the headgroup
due to the electrostatic repulsion, making way for micelles as a
favored packing mode of these molecules. At the same time, the PEG-
diacylglycerol compounds studied here are uncharged, with thus
effectively smaller headgroups, which makes it possible for them to
pack into bilayers, and to spontaneously form unilamellar liposomes
(self-emulsifying compounds).
Because of the peculiar and complicated phase behavior of GDP-
PEG23, exhibiting phase transition above room temperature, and a
strong temperature hysteresis, a 1:1 w/wmixture of GDP-PEG23with
soy lecithinwas prepared, further referred to as Liposome concentrate
(LipConc). The LipConc mixture was found to combine the spontane-
ous liposome forming ability of the PEG lipid with the lack of a phase
transition in the physiologically relevant temperature range, typical
for the natural extracts (see below). According to the calorimetric
data, it undergoes amelting transition at ∼12 °C (data not illustrated).
At room and physiological temperatures, it is arranged into highly
swollen, uncorrelated lamellae (see X-ray patterns below) similar to
those of the liquid crystalline GDP-PEG23. Indeed, such uncorrelated,
irregular bilayers could be seen in the micrographs (Fig. 4).
3.1.2. GDO-PEG12
Aqueous dispersions of GDO-PEG12 do not exhibit calorimetric
transitions in the temperature interval 5–95 °C. It is typical for lipids
with unsaturated oleoyl hydrocarbon chains to exhibit gel-liquid
crystalline transitions at temperatures below 0 °C [16].
The X-ray diffraction pattern of GDO-PEG12 dispersions is
dominated by a broad hump centered at ∼5 nm (Fig. 5A), character-
istic of small disordered aggregates, possibly liposomes. They coexist
with a small portion of highly swollen lamellar arrays, as judged by
the minor diffraction peak at ∼11.9 nm. The latter peak disappears at
∼47 °C upon heating, and the system seems fully disordered and non-
diffracting at higher temperatures. On cooling, the swollen lamellae
are replaced by highly ordered lamellar phase at temperatures below
46 °C, with a lamellar repeat period d=5.6 nm.
In equimolar mixture with DOPE (frequently used as a “helper
lipid” in drug delivery lipid formulations) GDO-PEG12 exhibits the
phase sequence: lamellar→bilayer cubic (Pn3m)→hexagonal→mi-
cellar cubic (Fd3m)→micellar phase upon heating from 20 °C to 90 °C
(Fig. 5B).
Fig. 4. Thin section of LipConc MLV embedded in Eponate resin; bar—1 µm.
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Both GDP-PEG23 and GDO-PEG12 form liposomes spontaneously
upon hydration. Their size and morphology were examined by
dynamic light scattering (DLS) and electron microscopy.
At 25 °C large, micron-size aggregates form in GDP-PEG23
(Fig. 6A). Upon heating above the melting transition they reorganize
into liposomes of ∼130 nm mean diameter (Fig. 6B). The liposome
sizes of GDO-PEG12 are somewhat larger, with 180–200 nm diameter
(Fig. 6C); strong (over twofold) size decrease was observed with the
GDO-PEG12 liposomes on heating from 25 to 60 °C. In PBS dispersions
the particle sizes were similar to those in water. These sizes are
considerably larger than those reported for sonicated phosphatidyl-
choline vesicles, d∼15–20 nm, but smaller than the multilamellar
phosphatidylcholine vesicles forming spontaneously [17]. The poly-Fig. 5. SAXD patterns of a GDO-PEG12 aqueous dispersion (A) and GDdispersity index range for the GDP-PEG23 and GDO-PEG12 liposomes
was typically 0.2–0.4.
The liposomes prepared using LipConc are smaller (100–200 nm)
than those of GDO-PEG12. Their size is also much less sensitive to
temperature relative to the GDO-PEG12 liposomes, yet still more
sensitive than regular phosphatidylcholine unilamellar liposomes
[18].
3.3. Liposomes prepared by GDO-PEG12 or LipConc exchange lipids with
the membranes much more actively than common lecithin liposomes
Differential scanning calorimetry was used to examine the lipid
exchange between model phosphatidylcholine membranes and
liposomes of GDO-PEG12 or LipConc. In mixtures, transition tem-
peratures are informative about the mode of mixing (i.e., the
homogeneity of the mixture) and depend on composition. For
miscible components, the transition temperature can be used as a
measure of composition. Thus, the changes of the lipid phase
transition parameters (temperature, shape) upon consecutive tem-
perature scans were used as an indication of lipid mixing between
aggregates, as described earlier [19].
The usual approach to lipid mixing includes preparation of
molecular mixtures in organic solvent, with subsequent solvent
removal and hydration. This procedure is believed to produce
essentially equilibrium mixtures, but it is not quite biologically
relevant, since in biological systems, lipid exchange can take place
in an aqueous medium. We thus used lipids premixed in chloroform
as reference samples for complete, equilibrium lipid mixing. These
control samples were compared to samples in which lipid aqueous
dispersions were prepared separately, then mixed extempore in
water, and successive heating–cooling thermograms through their
solid–liquid crystalline phase transition were recorded. Since transi-
tion thermodynamic parameters are strongly sensitive to the
composition, they were taken as an indication for lipid mixing [19].
Mixture of DPPC and GDO-PEG12 prepared by premixing of the
lipids in chloroform exhibits phase transition centered at 38 °C
(Fig. 7A, top). When DPPC and GDO-PEG12 liposomes were mixed
as aqueous dispersions at 5–10 °C and immediately scanned in the
calorimeter, a double endotherm (two peak) was recorded, with
peaks at 38 °C and 41 °C (Fig. 7A). A transition temperature of 41 °C is
characteristic for the pure DPPC dispersions [16], and is thus aO-PEG12/DOPE mixture (B), recorded upon temperature scans.
Fig. 6. Particle size distributions of aqueous dispersions of GDP-PEG23 at 25 °C (A) and at 50 °C (B), and GDO-PEG12 at 25 °C, as recorded by dynamic light scattering.
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During subsequent heating scans, the peak at 41 °C disappeared, and
only the peak at 38 °C, virtually equivalent to that of the chloroform-
premixed sample, was observed during the 3rd heating scan.
Variations of the lipid concentration between 1 and 10 wt.% did not
inﬂuence the rate of change of the transition temperature. These
results are compatible with monomeric exchange through the
aqueous medium and not upon vesicle collision [19].
For comparison, a similar experiment was performed with lipo-
somes of DPPC and the non-PEGylated DOPC (Fig. 7B). The chloroform-
premixed DPPC/DOPC sample exhibits a broad transition at 31 °C
(Fig. 7B, top). The mixture of DPPC and DOPC aqueous liposome
dispersions exhibits sharp endotherm at 41 °C and a small one at 35 °C,
typical for the DPPC main transition and pretransition, respectively.
Subsequent heating scans result in only a negligible increase in themain
transition half-width, indicative of only an insigniﬁcant inclusion of
DOPC admixtures in the DPPC liposomes. Lipid transfer is thus strongly
suppressed between the phosphatidylcholine liposomes.
Relatively fast lipid exchange, although not as fast as that
demonstrated by GDO-PEG12, was measured for LipConc liposomes
as well (Fig. 7C).
Thus, exchange via lipid monomers is considerably more active for
the PEG lipids than for the common phosphatidylcholines, presum-
ably due to the higher monomer solubility of the PEGylated lipids
[20,21]. Such an active lipid exchange is evidently an advantage for
drug delivery applications, because it would facilitate the discharging
of the liposome “cargo”. Since the presence of the PEG-chains at the
liposome surface would prevent close contact and fusion of liposomes
with cell membranes (thereby prolonging the circulation time in
vivo), it is necessary to have a mechanism of releasing the carried
drug. The process of relatively facile lipid exchange reveals such an
alternative mechanism for drug release from the PEG-lipid liposomes.
The observed strong temperature dependence of the GDO-PEG12
liposome size is perhaps also a consequence of the high lipid monomer
concentration (CMC) in water and its pronounced temperature
dependence.
3.4. Liposome digestion by plasma macrophages
Plasma monocytes were incubated in macrophage SFM media
(12065-074) in 6 well plates in an incubator with a 5% CO2, at 37 °C to
mature to macrophages at 106 cells/well. The cells were incubated for
an additional 60 min in the presence of 500 ng PEG-23 GDP liposomes
followed by additional 15 min incubation with 0.25% Trypsin-EDTA.
The macrophage suspension was centrifuged at 2000 rpm for 5 min.
The pellet was ﬁxed with 4% PFA in PBS overnight and processed for
transmission electron microscopy (Fig. 8). The micrograph visualizes
liposomes internalized within the macrophages.3.5. Incorporation of lipophilic dietary supplements in LipConc liposomes
3.5.1. Fish oil and immune oil
Fish oil contains the omega-3 fatty acids eicosapentaenoic acid and
docosahexaenoic acid, precursors to eicosanoids that reduce inﬂam-
mation throughout the body, and for this reason are highly
recommended for a healthy diet.
At low concentrations (10–20 wt.%) ﬁsh oil stabilizes the LipConc
bilayers (Fig. 9A). Thus, LipConc samples with 10 wt.% and 20 wt.%
ﬁsh oil form expanded lamellar phase, with a lamellar repeat period of
∼10 nm. The change of the bilayer structure and ordering is indicative
for the inclusion of ﬁsh oil into the lipid bilayers. By presumably
“dissolving” amongst the lipid molecules, rather than into the
hydrophobic bilayer part, it effectively suppresses the intrinsic bilayer
curvature imposed by the bulky PEG chains. At 35 wt.% ﬁsh oil,
bilayers are still observable into the diffraction pattern, coexisting
with aggregates giving rise to the hump at ∼5–5.3 nm, presumably
unilamellar liposomes (Fig. 9A). At 50 wt.% and 70 wt.% ﬁsh oil the
system is strongly disordered. The hydrated pure ﬁsh oil samples do not
exhibit diffraction patterns—they presumably form oil drops, so dif-
fraction was not expected. Thus the samples with more than 20 wt.%
ﬁsh oil are supposedly phase separated, with coexisting LipConc
liposomes incorporating ∼20 wt.% ﬁsh oil, and ﬁsh oil drops most likely
decorated with a lipid shell.
Similarly to the ﬁsh oil, addition of 20 wt.% immune oil produces
bilayer stabilization (Fig. 9A). Thus immune oil at this concentration is
apparently incorporated into the LipConc bilayers.
The samples for these experiments were prepared bymixing of the
lipid and ﬁsh oil as chloroform solutions, with subsequent chloroform
evaporation and hydration (because this way it is easier to precisely
control the ratio of the components in small samples). Control
samples with 20 wt.% and 30 wt.% ﬁsh oil in LipConc prepared by
mixing of the dry substances and subsequent hydration exhibited the
same (even better) ordering and supplement incorporation (Fig. 10).
We thus conclude that ﬁsh oil can be incorporated in LipConc
liposomes up to ∼20–30 wt.%. Dry mixing the two components is
possible and gives identical results to themixing from organic solvent.
3.5.2. Coenzyme Q10
Coenzyme Q (CoQ), also known as ubiquinone, is a biologically
active quinone with an isoprenoid side chain, related in structure to
vitamin K and vitamin E. The various kinds of Coenzyme Q can be
distinguished by the number of isoprenoid side chains they have. The
most common CoQ in human mitochondria is CoQ10. Because of its
ability to transfer electrons and therefore act as an antioxidant, CoQ10
has become a valued dietary supplement. CoQ10 has been widely
used for the treatment of heart disease (especially heart failure), gum
diseases, and also breast cancer.
Fig. 8. Thin section of Eponate embedded sample of plasma macrophages incubated
with PEG-23 GDP liposomes for 60 min in 5% CO2 incubator at 37 °C; arrows point at the
internalized liposomes; bar=500 nm.
Fig. 7. Heating thermograms of DPPC/GDO-PEG12 (A), DPPC/DOPC (B) and DPPC/
LipConc (C) mixtures, prepared as separate dispersions and mixed extempore, or
premixed in chloroform, as indicated (thermograms have been vertically moved in
order to facilitate the ﬁgure readability).
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with a lamellar spacing d=5.7 nm, at room temperature and at 37 °C
(Fig. 9B, top). Upon heating, the lamellar ordering is lost at ∼60 °C,
and no diffraction pattern is observed above that temperature—the
sample probably transforms into micelles or oil drops after melting, as
previously reported [22]. The transition is slowly reversible—severalhours equilibration at room temperature are necessary before the
lamellar diffraction pattern reappears.
When mixed with LipConc, 10 wt.% and 20 wt.% CoQ10 stabilize
the liposome bilayers, and, similarly to the ﬁsh oil, appear incorpo-
rated into the bilayer (Fig. 9B). At 35 wt.% CoQ10, according to the
diffraction pattern the sample seems phase separated and a phase
with CoQ10-saturated lipid bilayers coexists with (nearly) pure
CoQ10 lamellae. After heating to above 60 °C, the components mix,
and stay mixed upon cooling down to room temperature for several
hours. At a higher concentration of CoQ10 (50 and 70 wt.%) it seems
immiscible with the liposomes even after heating. Thus, an immis-
cibility composition range at N20 wt.% CoQ10 obviously exists in the
LipConc/CoQ10 phase diagram. This result is in accord with
previously published data for DPPC/CoQ10 mixtures [23].
The samples were prepared by mixing the components as
chloroform solutions, with subsequent chloroform evaporation and
hydration. Since the source CoQ10 was a powder, dry mixing test has
not been performed.
Thus, we conclude that CoQ10 can be incorporated in LipConc
liposomes up to ∼20–25 wt.%; for a higher concentration (∼35 wt.%)
it would necessary to heat the dispersion to N60 °C, and to lyophilize it
immediately upon cooling to room temperature, within several hours,
in order to avoid phase separation.3.5.3. Vitamin D
Vitamin D (VitD) refers to a group of lipophilic prohormones, the
twomajor forms of which are vitamin D2 (ergocalciferol) and vitamin
D3 (cholecalciferol). The term vitamin D also refers to metabolites and
other analogues of these substances. Vitamin D3 is produced in skin
exposed to sunlight, speciﬁcally ultraviolet B radiation. Vitamin D
plays an important role in the maintenance of several organ systems.
It regulates the calcium and phosphorus levels in the blood by
promoting their absorption from food in the intestines and by
promoting reabsorption of calcium in the kidneys; it promotes bone
formation and mineralization and is essential in the development of
an intact and strong skeleton; it also affects the immune system by
promoting immunosuppression and anti-tumor activity.
The hydrated VitD samples do not exhibit ordering, as manifested
by the lack of small-angle diffraction. Addition of 10, 20, and 35 wt.%
of VitD to the LipConc liposomes strongly inﬂuenced the bilayer
ordering (Fig. 9C) and was thus indicative of inclusion of the drug into
Fig. 9. SAXD patterns of: (A) LipConc/ﬁsh oil (and immune oil—dotted line); (B) LipConc/CoQ10; (C) LipConc/VitD; and (D) LipConc/VitE mixtures at different compositions,
recorded at 37 °C.
Fig. 10. SAXD patterns at 37 °C of mixtures of LipConc with ﬁsh oil, VitD and VitE,
prepared by direct mixing of the compounds and subsequent hydration, without
chloroform premixing.
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lamellar ordering anymore (Fig. 9C).
The above samples were prepared by mixing of the lipid and drug
as chloroform solutions. Control samples with 20 wt.% and 40 wt.%
VitD were prepared by mixing of the dry substances. The 20 wt.%
sample exhibited the same organization as that mixed in chloroform.
Lamellar ordering was not observed at 40 wt.% VitD dry mixed with
LipConc (Fig. 10). Hence, VitD can be incorporated in LipConc
liposomes up to ∼35 wt.%. Dry mixing of the two components is
possible at those concentrations.
3.5.4. Vitamin E
Tocopherol, or vitamin E (VitE), is a lipophilic vitamin that is an
important antioxidant; it is also essential in the formation of red blood
cells. Tocopherol occurs in eight different isoforms; α-tocopherol is a
form of vitamin E that appears to have the greatest nutritional
signiﬁcance.
The behavior of the LipConc/VitE mixture is more complicated than
those of the other drugs above and required more experimentation.
Samples of 10 wt.% and 20 wt.% VitE behave similarly to those with
the additives discussed above: they are well-ordered, with lamellar
spacings d∼9.5–10 nm, and the drug appears incorporated into the
liposome bilayers, as judged from the changes in the structural
653R. Koynova, M. Tihova / Biochimica et Biophysica Acta 1798 (2010) 646–653parameters of the bilayers (Fig. 9D). At 35 wt.%, however, the sample
is obviously phase separated into two components, and did not
homogenize at any temperature up to 90 °C. The sample with 50 wt.%
VitE was strongly disordered. Remarkably, a sample of 70 wt.% VitE
again displayed good lamellar organization, but different of that at
10 wt.% and 20 wt.% VitE—with largely expanded lamellar period,
d∼12 nm. Noteworthy, this sample also looked very different from all
other samples—very dense white sticky substance. The pattern of the
pure hydrated VitE was also peculiar and difﬁcult to interpret.
Obviously, the phase diagram of this mixture is complicated and
requires special investigation, which was out of the scope of the
present study. Anyway, it appears safe to incorporate up to 20 wt.%
VitE into the LipConc liposomes.
3.5.5. Fish oil, VitD and VitE mix with LipConc in dry state in virtually the
same way as in chloroform solution
For industrial applications, it is often technologically easier and
safer if the liposome lipid and the additives could be dry-mixed,
avoiding the troublesome mixing in organic solvent with subsequent
solvent evaporation. With this motivation, we performed control
experiments with mixing LipConc with ﬁsh oil, VitD, or VitE as dry
substances, with subsequent hydration.
The X-ray patterns of these “dry” samples (Fig. 10) are virtually the
same as those of samples in which the components have been mixed
as chloroform solution, with subsequent chloroform evaporation and
subsequent hydration. There was no indication for phase separation,
or differences in the structural organization suggestive for a different
component ratio when applying the two different protocols. This
was taken as indicative for identical sample organization in the two
preparations.
4. Conclusions
– Hydrated GDP-PEG23 and GDO-PEG12 both form lamellar liquid
crystalline phase, and morphologically arrange into uni- or
oligolamellar liposomes; the liposomes form spontaneously upon
hydration. This is in distinct difference from the PEGylated
phospholipids which only form micelles but not liposomes, and
is possibly due to the lack of electric charge in the PEG-
diacylglycerol conjugate headgroups. The formation of liposomes
might be advantageous for drug delivery because of their higher
encapsulation capacity.
– GDP-PEG23 exhibits peculiar phase behavior and can form a long-
living hexagonal phase at ambient and physiological temperatures.
This feature might be important for drug delivery applications,
since nonlamellar phase formation is known to facilitate the
release of the content of lipid vehicles.
– The GDO-PEG12 liposomes are bigger than the sonicated phos-
pholipid vesicles; their size exhibits pronounced temperature
dependence.
– GDO-PEG12 and LipConc liposomes exchange lipids with the
membranes much more actively than common lecithin liposomes,
presumably due to the higher monomer solubility (CMC) of the
PEGylated lipids. Suchanactive lipid exchangemightbeanadvantage
for drug delivery applications, because it would facilitate the
discharging of the liposome cargo upon uptake and internalization.
– Liposomes of LipConc formulation might be used for incorporation
and delivery of lipophilic dietary supplements.
– Fish oil can be incorporated in LipConc liposomes up to ∼20–
30 wt.%. Dry mixing of the two components is feasible and gives
identical results to the mixing in organic solvent.
– CoQ10 can be incorporated in LipConc liposomes up to∼ 20–25 wt.%;
for incorporation of higher concentration (∼35 wt.%) it would be
necessary to heat the dispersion to N60 °C, and to lyophilize it
immediately upon cooling to room temperature, within several
hours, in order to avoid phase separation.– Vitamin D can be incorporated in LipConc liposomes up to∼35 wt.%.
Dry mixing of the two components is achievable at those
concentrations.
– Vitamin E can be incorporated in LipConc liposomes up to ∼20 wt.%.Acknowledgements
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